Clinical experiences of guided tapering of antipsychotics for patients with schizophrenia- a case series

被引:3
作者
Molgaard, Sofie Norlin [1 ]
Nielsen, Mette odegaard [1 ]
Roed, Kickan [2 ]
Nielsen, Jimmi [1 ]
机构
[1] Copenhagen Univ Hosp, Mental Hlth Ctr Glostrup, Unit complicated schizophrenia, Glostrup, Denmark
[2] Copenhagen Univ Hosp, Mental Hlth Ctr Glostrup, Ctr Appl Res Mental Hlth Care, Mental Hlth Serv CPH, Glostrup, Denmark
关键词
Schizophrenia; Antipsychotic medication; Dose reduction; Tapering; Recovery; Relapse; SHARED DECISION-MAKING; REMITTED 1ST-EPISODE PSYCHOSIS; MAINTENANCE TREATMENT; MENTAL-HEALTH; 1ST EPISODE; FOLLOW-UP; RECOVERY; NONADHERENCE; MEDICATION;
D O I
10.1186/s12888-024-05699-y
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background 80% of patients value information on treatment options as an important part of recovery, further patients with a history of psychotic episodes feel excluded from decision making about their antipsychotic treatment, and on top of that, mental health staff is prone to be reluctant to support shared decision making and medication tapering for patients with schizophrenia. This case series aims to demonstrate the tapering of antipsychotic medication and how guided tapering affects the patient's feeling of autonomy and psychiatric rehabilitation.Case presentation We present six patients diagnosed with schizophrenia (International Classification of Mental and Behavioral Disorders- 10th Edition codes F20.0-5, F20.7-9) who underwent professionally guided tapering in our clinic. The clinic aims to guide the patients to identify the lowest possible dose of antipsychotic medication in a safe setting to minimise the risk of severe relapse. Two patients completely discontinued their antipsychotic medication, two suffered a relapse during tapering, one chose to stop the tapering at a low dose, and one patient with treatment resistant schizophrenia, which is still tapering down.Conclusions Reducing the antipsychotic dose increased emotional awareness in some patients (n = 4) helping them to develop better strategies to handle stress and increased feelings of recovery. Patients felt a greater sense of autonomy and empowerment during the tapering process, even when discontinuation was not possible. Increased awareness in patients and early intervention during relapse may prevent severe relapse.Impact and implications Some patients with schizophrenia might be over medicated, leading to unwanted side effects and the wish to reduce their medication. The patients in our study illustrate how guided tapering of antipsychotic medication done jointly with the patient can lead to improved emotional awareness and the development of effective symptom management strategies. This may in turn lead to a greater sense of empowerment and identity and give life more meaning, supporting the experience of personal recovery.
引用
收藏
页数:8
相关论文
共 41 条
[1]   Shared decision making in mental health: the importance for current clinical practice [J].
Alguera-Lara, Victoria ;
Dowsey, Michelle M. ;
Ride, Jemimah ;
Kinder, Skye ;
Castle, David .
AUSTRALASIAN PSYCHIATRY, 2017, 25 (06) :578-582
[2]  
[Anonymous], 1992, ICD-10: International classification of diseases and related health problems
[3]   Treatment of adult patients with schizophrenia and complex mental health needs - A national clinical guideline [J].
Baandrup, Lone ;
Rasmussen, Jesper Ostrup ;
Klokker, Louise ;
Austin, Stephen ;
Bjornshave, Thomas ;
Bliksted, Vibeke Fuglsang ;
Fink-Jensen, Anders ;
Fohlmann, Allan Hedegaard ;
Hansen, Jens Peter ;
Nielsen, Malene Kristine ;
Sandsten, Karl Erik ;
Schultz, Vilhelm ;
Voss-Knude, Susanne ;
Nordentoft, Merete .
NORDIC JOURNAL OF PSYCHIATRY, 2016, 70 (03) :231-240
[4]   To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial [J].
Begemann, Marieke J. H. ;
Thompson, Ilse A. ;
Veling, Wim ;
Gangadin, Shiral S. ;
Geraets, Chris N. W. ;
van 't Hag, Erna ;
Mueller-Kuperus, Sanne J. ;
Oomen, Priscilla P. ;
Voppel, Alban E. ;
van der Gaag, Mark ;
Kikkert, Martijn J. ;
Van Os, Jim ;
Smit, H. Filip E. ;
Knegtering, Rikus H. ;
Wiersma, Sybren ;
Stouten, Luyken H. ;
Gijsman, Harm J. ;
Wunderink, Lex ;
Staring, Anton B. P. ;
Veerman, Selene R. T. ;
Mahabir, Amrita G. S. ;
Kurkamp, Jorg ;
Pijnenborg, Gerdina H. M. ;
Veen, Natalie D. ;
Marcelis, Machteld ;
Grootens, Koen P. ;
Faber, Gunnar ;
van Beveren, Nico J. ;
Been, Agaath ;
van den Brink, Truus ;
Bak, Maarten ;
van Amelsvoort, Therese A. M. J. ;
Ruissen, Andrea ;
Blanke, Christine ;
Groen, Karin ;
de Haan, Lieuwe ;
Sommer, Iris E. C. .
TRIALS, 2020, 21 (01)
[5]   Shared decision-making in the medical encounter: What does it mean? (Or it takes at least two to tango) [J].
Charles, C ;
Gafni, A ;
Whelan, T .
SOCIAL SCIENCE & MEDICINE, 1997, 44 (05) :681-692
[6]  
Chen E. Y. H., 2010, BMJ, V341
[7]   Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics [J].
Correll, Christoph U. ;
Martin, Amber ;
Patel, Charmi ;
Benson, Carmela ;
Goulding, Rebecca ;
Kern-Sliwa, Jennifer ;
Joshi, Kruti ;
Schiller, Emma ;
Kim, Edward .
SCHIZOPHRENIA, 2022, 8 (01)
[8]   What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia? [J].
Correll, Christoph U. ;
Rubio, Jose M. ;
Kane, John M. .
WORLD PSYCHIATRY, 2018, 17 (02) :149-160
[9]   A network meta-analysis of efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia [J].
Dong, Shimeng ;
Schneider-Thoma, Johannes ;
Bighelli, Irene ;
Siafis, Spyridon ;
Wang, Dongfang ;
Burschinski, Angelika ;
Schestag, Kristina ;
Samara, Myrto ;
Leucht, Stefan .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2024, 274 (04) :917-928
[10]  
Gupta S, 2018, BJPSYCH ADV, V24, P295, DOI [10.1192/bja.2018.2, 10.1192/bja.2018.2, DOI 10.1192/BJA.2018.2]